Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe Mounjaro KwikPen 15 mg is a prescription-only medicine, which means the only legal route to it in the UK is through a qualified prescriber following a clinical assessment. No pharmacy — online or otherwise — can lawfully supply it without one. Once a prescriber confirms you are suitable, a Mounjaro KwikPen can be dispensed through a GPhC-registered pharmacy, with your pen typically arriving the next working day. At nume, every order is personally reviewed by a GPhC-registered Independent Prescriber on the same day you apply.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The Mounjaro 15 mg KwikPen sits at the top of the licensed dose range for tirzepatide in the UK. Treatment does not start there. Under the SmPC, prescribers begin at 2.5 mg (a tolerability phase that lets your body adjust) and increase the dose in steps, typically every four weeks, working up through 5, 7.5, 10 and 12.5 mg before reaching 15 mg. That process takes several months. Trying to jump straight to the highest dose is not clinically appropriate and no legitimate prescriber will sanction it.
At each step, a responsible service checks that you are responding well and tolerating the treatment before approving the next increase. At nume, dose increases require clinical evidence (not just a tick-box) which is why our prescribers review every repeat order personally. You can read more about how that works on our 15 mg supply and review page.
The evidence underpinning this dose is substantial. In the SURMOUNT-1 trial, published in the New England Journal of Medicine, participants using tirzepatide at 15 mg achieved an average body-weight reduction of around 20–21% over 72 weeks alongside lifestyle changes. Those figures come from a controlled clinical setting, and individual results will vary, but they are why 15 mg is the maintenance target many people work towards with their prescriber.
Before applying anywhere, it helps to be clear about two separate choices. First: NHS or private? The NHS is rolling out tirzepatide under strict phased criteria, currently requiring a BMI of 40 or above alongside four or more specific weight-related conditions. If you meet those thresholds you may qualify; if not, a private prescription is the lawful alternative. Both routes require clinical assessment. There is no shortcut.
Second: if you go private, which pharmacy? This matters more than many people realise. The MHRA has issued repeated warnings about counterfeit weight-loss pens sold through social media and unverified websites, fake pens have contained dangerous substances, including insulin. The safe check is simple: look up any online pharmacy on the GPhC register at pharmacyregulation.org/registers. If it does not appear, do not use it. Red flags include sellers offering these medicines without a prescription, prices dramatically below the market, or discount codes for what are prescription-only medicines.
nume's GPhC premises registration is 9012878, verifiable directly on the register. Our medicines move through the licensed UK supply chain with Eli Lilly as an authorised supplier. That is not a marketing claim; it is something you can verify before you apply.
Private eligibility for Mounjaro broadly follows the licensed criteria: adults with a BMI of 30 or above, or a BMI of 27 or above alongside at least one weight-related condition such as high blood pressure, type 2 diabetes, high cholesterol or obstructive sleep apnoea. For some ethnic backgrounds, UK guidance applies thresholds 2.5 kg/m² lower, your prescriber will factor this in.
Eligibility for the 15 mg pen specifically depends on your treatment history, not just your BMI. Prescribers at a service like ours will ask for evidence that you have been on treatment and are responding appropriately before approving this dose, and if you are ready to move to that stage you can buy Mounjaro 15 mg through our clinic once your prescriber has confirmed you meet the criteria. Patients transferring from another provider need to supply records of their current dose. If you are just beginning, the journey to 15 mg takes time, and that is by design, not bureaucracy.
Mounjaro is not recommended during pregnancy, for those breastfeeding, or for anyone trying to conceive. It is not licensed for under-18s. These exclusions apply regardless of dose. If any of these apply to you, tell our clinical team when you consult, you can reach them directly if you have questions before starting.
The process is straightforward. You complete a free clinical consultation through our site, answering questions reviewed (the same day) by a GPhC-registered Independent Prescriber. Identity and weight are verified; for dose increases, clinical evidence is checked. If your application is approved and you place your order before 12pm on a working day, your Mounjaro KwikPen is dispatched that afternoon and delivered the next working day by DPD, and if you need to stock up on supplies you can also buy Mounjaro KwikPen needles alongside your pen order. The pen arrives in plain packaging; the tracking link comes to your phone.
Storage is worth thinking about before your first pen arrives: Mounjaro needs to be kept refrigerated at 2–8°C. Lots of patients keep it in the fridge door next to everyday items, practical, easy to remember, and away from the freezer section where temperature can drop too low. For the exact room-temperature window if you need to carry it, the Mounjaro SmPC on the eMC has the definitive figure; your Patient Information Leaflet covers this too.
If you want to understand the broader picture of weight-loss treatment options before deciding, that is worth doing. And if you are curious about how the online prescription process compares to other routes, our clinical overview covers the detail. When you are ready, the starting point is the same for everyone.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.